You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 19, May 17, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Arrhythmias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevention of Atrial Fibrillation Following Cardiac Surgery

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their randomized controlled trial of prophylactic amiodarone therapy for the prevention of atrial fibrillation after heart surgery, Dr Mitchell and colleagues1 found that treatment with amiodarone compared with placebo resulted in a 48% reduction in the primary end point, defined as an atrial tachyarrhythmia lasting 5 minutes or longer that prompted treatment by the attending physician. We have a number of questions related to the study design and analysis.

First, the potential confounding effect of beta-blocker withdrawal was not considered.2 Patients who have had treatment with a beta-blocker withdrawn have been found to have twice the likelihood of developing postoperative atrial fibrillation.3 In the present study, rates of beta-blocker use both before and after surgery were recorded, so withdrawal rates of beta-blockers could be derived and reported.

Second, the authors state that serum amiodarone levels were determined on the day of surgery but do not specifically . . . [Full Text of this Article]

Brian J. Potter, MD
brian.potter@umontreal.ca
Notre-Dame Hospital

Jacques LeLorier, MD, PhD, FRCPC
Centre de Recherche de l'Hôtel-Dieu du CHUM
Centre Hospitalier de l’Université de Montréal
Montréal, Quebec



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Prevention of Atrial Fibrillation Following Cardiac Surgery
Miguel A. Arias
JAMA. 2006;295(19):2247.
EXTRACT | FULL TEXT  

Prevention of Atrial Fibrillation Following Cardiac Surgery
Madan M. Kwatra
JAMA. 2006;295(19):2247-2248.
EXTRACT | FULL TEXT  

Prevention of Atrial Fibrillation Following Cardiac Surgery—Reply
L. Brent Mitchell and Derek V. Exner
JAMA. 2006;295(19):2248.
EXTRACT | FULL TEXT  

Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial
L. Brent Mitchell, Derek V. Exner, D. George Wyse, Carol J. Connolly, Gregory D. Prystai, Alexander J. Bayes, William T. Kidd, Teresa Kieser, John J. Burgess, André Ferland, Charles L. MacAdams, and Andrew Maitland
JAMA. 2005;294(24):3093-3100.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.